3645 Medical Net , Inc. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

3645

TSE Growth

Medical Net , Inc.

301

JPY

-1

(-0.33%)

Dec 5, 2:26 pm JST

1.94

USD

Dec 5, 12:26 am EST

Result

PTS

outside of trading hours

301.1

Dec 5, 1:06 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
May, 2022	3,745	445	449	380	43.4	4	Jul 13, 2022	J-GAAP
May, 2023	4,500	379	431	116	13.0	2.50	Jul 18, 2023	J-GAAP
May, 2024	5,252	298	322	5	0.7	3	Jul 12, 2024	J-GAAP
May, 2025	6,077	98	134	-68	-7.6	3	Jul 18, 2025	J-GAAP
May, 2026 Guidance	6,400	270	233	121	13.1	3	Jul 18, 2025	J-GAAP
YoY	+5.3%	+175.5%	+73.9%	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
May, 2021	Jul 14, 2020	3,200	155	155	ー	－	J-GAAP
- -	Dec 11, 2020	3,209	300	275	ー	－	J-GAAP
- -	Jan 12, 2021	3,209	300	275	ー	4	J-GAAP
- Results	Jul 14, 2021	2,904	331	336	129	4	J-GAAP
May, 2022	Jul 14, 2021	Available in future release
	Oct 12, 2021
	Apr 14, 2022
Results	Jul 13, 2022
May, 2023	Jul 13, 2022
	Jun 29, 2023
Results	Jul 18, 2023
May, 2024	Jul 18, 2023
Results	Jul 12, 2024
May, 2025	Jul 12, 2024
Results	Jul 18, 2025
May, 2026	Jul 18, 2025	6,400	270	233	121	3	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
May, 2006	176	－	Available in future release
May, 2007	315	+79.0
May, 2008	519	+64.8
May, 2009	785	+51.3
May, 2010	1,037	+32.1
May, 2011	1,195	+15.2
May, 2012	1,054	-11.8
May, 2013	1,163	+10.3
May, 2014	1,268	+9.0
May, 2015	1,258	-0.8
May, 2016	1,482	+17.8
May, 2017	1,480	-0.1
May, 2018	1,740	+17.6
May, 2019	2,236	+28.5
May, 2020	2,917	+30.5
May, 2021	2,904	-0.4
May, 2022	3,745	+29.0
May, 2023	4,500	+20.2
May, 2024	5,252	+16.7
May, 2025	6,077	+15.7
May, 2026 Guidance	6,400	+5.3	270	+175.5	233	+73.9	13.1	－

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
May, 2024	5,252	298	5.67	0.26	0.13	1.41	0.7
May, 2025	6,077	98	1.61	-3.75	-1.69	1.51	-7.6
May, 2026 Guidance	6,400	270	4.22	6.47	2.85	1.51	13.1

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	6,077	445	449	380	43.4
Fiscal Year	May, 2025	May, 2022	May, 2022	May, 2022	May, 2022

First Half

Result

Guidance History

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jun - Nov, 2022	1,997	177	205	116	13.1	0	Jan 13, 2023	J-GAAP
Jun - Nov, 2023	2,342	169	194	115	12.8	0	Jan 12, 2024	J-GAAP
Jun - Nov, 2024	2,912	47	67	-17	-1.9	－	Jan 14, 2025	J-GAAP
Jun - Nov, 2025 Guidance	3,085	74	51	11	1.2	0	Jul 18, 2025	J-GAAP
YoY	+5.9%	+57.4%	-23.9%	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Nov, 2022	Jul 13, 2022	2,131	114	115	65	0	J-GAAP
Results	Jan 13, 2023	1,997	177	205	116	0	J-GAAP
Nov, 2023	Jul 18, 2023	Available in future release
Results	Jan 12, 2024
Nov, 2024	Jul 12, 2024
Results	Jan 14, 2025
Nov, 2025	Jul 18, 2025	3,085	74	51	11	0	J-GAAP

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
May, 2023	379	367	429	-62	-17	1,513	43.64	J-GAAP
May, 2024	298	-166	119	-285	144	1,507	37.78	J-GAAP
May, 2025	98	-339	-80	-259	219	1,403	34.39	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jun - Aug, 2023	1,099	22	44	21	2.4	22.7	Oct 13, 2023	J-GAAP
Jun - Aug, 2024	1,358	-3	-3	-35	-3.9	ー	Oct 15, 2024	J-GAAP
Jun - Aug, 2025	1,561	24	53	21	2.4	103.9	Oct 15, 2025	J-GAAP
YoY	+14.9%	－	－	－	－

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Sep - Nov, 2023	1,243	147	150	94	10.5	11.8	Jan 12, 2024	J-GAAP
Dec - Feb, 2023	1,313	62	57	-69	-7.7	4.7	Apr 12, 2024	J-GAAP
Mar - May, 2024	1,597	67	71	-41	-5.4	4.2	Jul 12, 2024	J-GAAP
Jun - Aug, 2024	1,358	-3	-3	-35	-3.9	-0.2	Oct 15, 2024	J-GAAP
Sep - Nov, 2024	1,554	50	70	18	2.0	3.2	Jan 14, 2025	J-GAAP
Dec - Feb, 2024	1,509	12	23	-128	-14.3	0.8	Apr 18, 2025	J-GAAP
Mar - May, 2025	1,656	39	44	77	8.7	2.4	Jul 18, 2025	J-GAAP
Jun - Aug, 2025	1,561	24	53	21	2.4	1.5	Oct 15, 2025	J-GAAP
YoY	+14.9%	－	－	－	－

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Sep - Nov, 2020	781	+5.7	Available in future release
Dec - Feb, 2020	757	+3.6
Mar - May, 2021	748	+0.5
Jun - Aug, 2021	803	+29.9
Sep - Nov, 2021	899	+15.1
Dec - Feb, 2021	889	+17.4
Mar - May, 2022	1,154	+54.3
Jun - Aug, 2022	971	+20.9
Sep - Nov, 2022	1,026	+14.1
Dec - Feb, 2022	1,128	+26.9
Mar - May, 2023	1,375	+19.2
Jun - Aug, 2023	1,099	+13.2
Sep - Nov, 2023	1,243	+21.2
Dec - Feb, 2023	1,313	+16.4
Mar - May, 2024	1,597	+16.1
Jun - Aug, 2024	1,358	+23.6
Sep - Nov, 2024	1,554	+25.0
Dec - Feb, 2024	1,509	+14.9
Mar - May, 2025	1,656	+3.7
Jun - Aug, 2025	1,561	+14.9	24	－	53	－	2.4	－

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	1,656	150	150	147	17.1
Fiscal Year	May, 2025	Nov, 2021	Nov, 2023	Aug, 2021	Aug, 2021

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
May, 2023	211.94	55.3	3,467	1,917	1,710	0.41	Jul 18, 2023	J-GAAP
May, 2024	210.85	47.8	3,989	1,907	1,693	0.54	Jul 12, 2024	J-GAAP
May, 2025	196.50	42.0	4,080	1,715	1,598	0.73	Jul 18, 2025	J-GAAP
Jun - Aug, 2025	ー	44.0	4,246	1,869	1,593	0.65	Oct 15, 2025	J-GAAP

Medical Net , Inc.(3645) Financial Results